SINCE Laennec 1 first described and named bronchiectasis its etiology and mode of development have been controversial issues. Numerous theories have been advanced, each of which is backed by ...
Mark Metersky, MD, FCCP, illustrates the pathology of bronchiectasis. This is a video synopsis/summary of an Insights involving Mark Metersky, MD, FCCP, on bronchiectasis. Bronchiectasis is an ...
Brensocatib is the first approved therapy for non–cystic fibrosis bronchiectasis and the first dipeptidyl peptidase 1 inhibitor for neutrophil-mediated diseases. The ASPEN trial showed brensocatib ...
Bronchiectasis and chronic obstructive pulmonary disease (COPD) are two chronic conditions that involve damage to the lungs. The causes and treatments for each differ. In some instances, COPD may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results